MYOMO Insider Sales Spike: Executives Sell Shares to Cover Taxes Amid Falling Stock Prices

Insider Sales Signal a Tax‑Driven Exit? On June 12, 2026 Harry Kovelman, MYOMO’s Chief Medical Officer, sold 10,442 shares of common stock at $1.20 each, a move that appears purely to satisfy income‑tax liabilities triggered by the vesting of restricted stock units the day before. The sale lowered his post‑transaction holdings to 90,541 shares, a modest decline from the roughly 100,000‑share base he maintained since the June 8 and 9 transactions. While the transaction size is small relative to his total stake, the timing and accompanying footnote—“solely to pay income taxes”—suggest a routine tax‑cover rather than a strategic divestment.

Broader Insider Activity: A Quiet Balancing Act Kovelman’s sale sits alongside a broader pattern of insider activity. Mitchell Micah, the Chief Commercial Officer, and CFO David A Henry also sold shares on the same day, with Micah disposing of 9,061 shares and Henry of 10,969 shares. These moves align with a broader trend of officers selling to cover tax obligations following restricted‑unit vesting, as evidenced by the June 8/9 transactions in early June. In contrast, director Kirk Thomas F purchased 40,002 shares in early June, boosting his holding to nearly 694,000 shares. The net effect is a small increase in overall ownership concentration among senior executives, while the overall market supply of MYO shares remains relatively stable.

Implications for Investors For investors, the most salient takeaway is that the recent insider sales are largely transactional and not indicative of confidence erosion. MYOMO’s share price, which closed at $1.37 on June 10, has been under pressure, with a 10.16% weekly decline and a 58.78% year‑to‑date drop. The insider activity does not appear to be a catalyst for further price erosion; instead, it reflects routine tax planning. However, the high social‑media buzz (275.14 %) around the filing—despite a neutral sentiment score—may amplify short‑term volatility as market participants react to the headline of a senior officer selling shares.

Harry Kovelman: A Consistent, Conservative Seller Kovelman’s historical transaction record paints a picture of a cautious insider. Over the past year, he has sold 20,464 shares (May 27, 2026), 11,536 shares (May 28, 2026), and 7,635 shares (June 8, 2026) at prices ranging from $1.00 to $1.33, while maintaining a substantial long position. His only large purchase came on June 11, 2025, when he bought 62,938 shares at no cost—likely a vesting event with no cash outlay. The pattern suggests that Kovelman sells primarily to cover taxes or manage liquidity, not to signal a lack of confidence in the company’s prospects. His post‑transaction holdings consistently remain above 90,000 shares, indicating ongoing commitment to MYOMO’s long‑term strategy.

Outlook The insider sales, while notable for their timing, are part of a routine tax‑cover cycle that is common among executives with large restricted‑unit holdings. The company’s fundamentals—negative earnings (P/E of –4.28), a 52‑week low of $0.61, and a market cap of roughly $60 million—suggest a valuation below historical peaks, offering a potential entry point for value‑seeking investors. Nonetheless, the recent negative weekly trend and the company’s negative earnings signal caution. Investors should monitor upcoming quarterly reports and any new insider transactions for signs that insiders are shifting positions beyond mere tax coverage.